Sanctuary Advisors LLC lessened its holdings in shares of DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 7.1% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 9,432 shares of the company’s stock after selling 717 shares during the period. Sanctuary Advisors LLC’s holdings in DocuSign were worth $904,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Modus Advisors LLC acquired a new stake in DocuSign in the fourth quarter worth $36,000. Itau Unibanco Holding S.A. bought a new stake in shares of DocuSign in the third quarter worth about $28,000. Avion Wealth lifted its holdings in shares of DocuSign by 309.2% during the 4th quarter. Avion Wealth now owns 487 shares of the company’s stock valued at $43,000 after purchasing an additional 368 shares in the last quarter. Brooklyn Investment Group acquired a new position in shares of DocuSign in the 3rd quarter valued at approximately $33,000. Finally, Avior Wealth Management LLC raised its holdings in shares of DocuSign by 36.5% during the fourth quarter. Avior Wealth Management LLC now owns 542 shares of the company’s stock worth $49,000 after acquiring an additional 145 shares during the period. Institutional investors own 77.64% of the company’s stock.
Analysts Set New Price Targets
Several research firms have commented on DOCU. Wells Fargo & Company boosted their target price on DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a research note on Friday, December 6th. JPMorgan Chase & Co. increased their price target on DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a research report on Tuesday, December 3rd. Jefferies Financial Group upped their price objective on DocuSign from $80.00 to $95.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. HSBC restated a “reduce” rating on shares of DocuSign in a research note on Friday, December 6th. Finally, Citigroup upped their price target on shares of DocuSign from $87.00 to $113.00 and gave the company a “buy” rating in a research note on Friday, December 6th. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, DocuSign currently has an average rating of “Hold” and an average price target of $92.45.
Insider Buying and Selling
In other news, Director Teresa Briggs sold 534 shares of the stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $94.60, for a total value of $50,516.40. Following the completion of the transaction, the director now owns 7,736 shares of the company’s stock, valued at approximately $731,825.60. This represents a 6.46 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Allan C. Thygesen sold 7,763 shares of DocuSign stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $80.54, for a total transaction of $625,232.02. Following the sale, the chief executive officer now directly owns 100,062 shares in the company, valued at $8,058,993.48. This trade represents a 7.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 693,773 shares of company stock worth $66,727,926. Corporate insiders own 1.66% of the company’s stock.
DocuSign Stock Down 1.2 %
Shares of DocuSign stock opened at $81.28 on Friday. DocuSign, Inc. has a 12-month low of $48.70 and a 12-month high of $107.86. The company has a market capitalization of $16.42 billion, a price-to-earnings ratio of 16.76, a PEG ratio of 6.94 and a beta of 0.89. The firm’s 50-day moving average price is $90.65 and its two-hundred day moving average price is $77.36.
DocuSign Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Recommended Stories
- Five stocks we like better than DocuSign
- Are Penny Stocks a Good Fit for Your Portfolio?
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- Trading Stocks: RSI and Why it’s Useful
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.